glp 1 drugs news Medicare will now help pay for some GLP-1 drugs. Here's what to know What to know about Medicare

Description

These side effects can usually be reduced by initiating the medication at a low dose and titrating slowly

doi: 10.1016/J.BONE.2019.115197 121 FemminellaGDFrangouELoveSBBuszaGHolmesCRitchieCet al

Product Type Analysis The semaglutide segment led in 2024, claiming a market share of 58.4% owing to the clinical efficacy and widespread adoption of semaglutide-based products for both type 2 diabetes and obesity management

Additionally, research into novel delivery technologies, such as microneedle patches and implantable devices, holds the potential to further enhance patient convenience and compliance, thereby expanding the market reach and attractiveness of GLP-1 receptor agonists

For instance, according to the International Diabetes Federation Diabetes Atlas (2021 edition), China and India were estimated to have 140.9 million and 74.2 million adults with diabetes in 2021, and these numbers are projected to increase to 174.4 million and 124.9 million, respectively, by 2045